Persistent Head and Neck Cancer Following First-Line Treatment
<i>Background:</i> Following first-line treatment of head and neck cancer (HNC), persistent disease may require second-line treatment. <i>Methods:</i> All patients with HNC treated between 2008 and 2016 were included. Second-line treatment modalities and survival of patients...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/10/11/421 |